Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9616 posts found.

aedes_aegypti_mosquito

First-in-man Zika vaccine trials get green light

June 21, 2016 Manufacturing and Production, Research and Development trials, zika vaccine

Inovio Pharmaceuticals (NASDAQ: INO) and GeneOne Life Science (KSE: 011000) have announced that approval has been granted for the commencement …
News
esteban

Amgen appoints Esteban Santos as executive VP of operations

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amgen (NASDAQ: AMGN) has announced the appointment of Esteban Santos as executive vice president, operations. Santos will be responsible for …
Appointment
stocks1

Weekly Movers: Global Blood Therapeutics, Sophiris Bio…

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …
Feature
nhs_sign

NHS looking to offer free healthcare apps, devices from next year

June 20, 2016 Medical Communications, Research and Development, Sales and Marketing DigitalHealth, HealthTech, NHS, NICE

The NHS will offer devices and apps for free to help patients manage their health, starting in UK next year.
News
gsk_boronia_australia

GSK triple combo COPD therapy shows superiority in Phase III trials

June 20, 2016 Research and Development, Sales and Marketing COPD, GSK, phase III

GlaxoSmithKline (LSE: GSK), along with Innoviva (NASDAQ: INVA), have presented positive top-line results from a pivotal Phase III trial for …
News

Chi-Med to get $10 million milestone from AstraZeneca after initiation of expanded Phase II trials in NSCLC

June 20, 2016 Research and Development, Sales and Marketing AstraZeneca, Chi-Med, Iressa, Tagrisso, drug trial, lung cancer

Hutchison China MediTech (Nasdaq: HCM) on Monday said it is expanding Phase II trials in non-small cell lung cancer to …
News
lab

Federal panel to review proposal for first human CRISPR test

June 20, 2016 Research and Development, Sales and Marketing crispr, gene editing, human testing, oncology

A US Federal safety board is set to review a proposal for the first human use of the gene editing …
News

Nice backs BMS’ combination immunotherapy Opdivo, Yervoy to treat skin cancer

June 17, 2016 Medical Communications, Research and Development, Sales and Marketing BMS, NICE, oncology, opdivo, regulation, skin cancer

The National Institute for Health and Care Excellence (Nice) has backed a combination of Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) and …
News

Pfizer breaks ground on new $200 million biologics facility

June 17, 2016 Medical Communications, Research and Development Manufacturing Facility, Pfizer

Pfizer (NYSE: PFE) has broken ground on a new $200 million biologics clinical manufacturing facility in Andover, Massachusetts. This expansion …
News
6123892769_1befc31f38_o

WellBe bracelet, mobile app to help manage stress

June 17, 2016 Medical Communications, Research and Development HealthTech, WellBe, app, stress, wearable technology

Adding to the growing list of healthcare applications, a new technology claims to have created the first anti-stress biofeedback bracelet …
News
roche_close

Roche gets a NICE knockback for melanoma drug, Cotellic

June 16, 2016 Medical Communications, Research and Development, Sales and Marketing Cotellic, NICE, Roche

The National Institute for Health and Care Excellence (NICE) has announced that that it has not recommended Roche’s melanoma drug, …
News
chemo-web

SMC recommends treatment for potentially fatal chemotherapy-related disease

June 16, 2016 Research and Development, Sales and Marketing Menarini, SMC, adneuric

The Scottish Medicines Consortium has recommended Adenuric (febuxostat), a treatment for a severe complication that can affect chemotherapy patients in …
News
alzheimers_web_credit_shutterstock

Chiasma cuts staff by 33% after FDA rejects rare disease drug, Mycapssa

June 16, 2016 Research and Development, Sales and Marketing FDA, chiasma, cutbacks, failure, workforce cuts

US-based biopharmaceutical company, Chiasma (NASDAQ: CHMA), has announced substantial job cuts as it attempts to restructure following the US Food …
News
flag_-_union_flag

UK biotech in great shape, according to new industry report

June 16, 2016 Research and Development Europe, UK, biotech, uk bioindustry association

The UK biotechnology sector is going from strength to strength, having raised an “unprecedented” £900 million on the London Stock …
News
roche

Roche secures EU approval for Gazyvaro in new lymphoma indication

June 16, 2016 Research and Development, Sales and Marketing EU, Gazyvaro, Roche, follicular lymphoma

Roche (SIX: RO) has announced that the European Commission has approved Gazyvaro (obinutuzumab), in combination with bendamustine chemotherapy, in patients …
News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026